CoChat

The burden of allergic rhinitis: beyond dollars and cents

Fineman, Stanley M. · 2002 · Annals of Allergy, Asthma & Immunology

The DOI matches its Crossref record; 20 of the 22 references it cites were found in a registry or an index.

Abstract

Objective This article presents information about the economic burden of allergic rhinitis and its effect on quality of life. After reading this article, readers should have a greater awareness of the economic impact of this disease and how important it is for both patient and society to diagnose and treat it properly.Data sources Relevant and appropriately controlled clinical studies, data compiled from surveys and patient questionnaires, and studies of direct and indirect costs associated with allergic rhinitis were used. Only literature in the English language was reviewed.Study selection Material was taken from academic/scholarly journals and appropriate reviews.Results Allergic rhinitis occurs in approximately 20% of the general population in the United States. In recent years, its economic impact has increased, with spending for direct and indirect medical costs estimated between 1.5 and $2 billion a year. In addition to its financial burden, however, allergic rhinitis exacts a considerable toll on patients' quality of life, cognitive and learning functions, decision-making, and self-perception. Low energy levels associated with allergic rhinitis can lead to impairments of both memory and decision-making abilities.Conclusions Effective treatment and greater understanding on the part of both physicians and patients can help to reduce direct and indirect costs as well as to lessen the impact of allergic rhinitis on quality of life for both patient and society.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1081-1206(10)62022-4

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 20 references

Cited by

See all 102

Metadata

Authors
Fineman, S. M.
Venue
Annals of Allergy, Asthma & Immunology
Publisher
Elsevier BV
Published
2002-04
Volume
88
Issue
4
Pages
2-7
ISSN
1081-1206 (ISSN-L)
OpenAlex
W1977398752
Cited by
97
References
22
Citations by year
2025: 2 · 2024: 1 · 2023: 2 · 2021: 6 · 2020: 2 · 2019: 3 · 2018: 6 · 2017: 1 · 2016: 4 · 2015: 6 · 2014: 1 · 2013: 1 · 2012: 5
FWCI
3.83
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • Annals of Allergy Asthma & Immunology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
  • Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
Keywords
allergic rhinitis, economic burden, quality of life, direct and indirect costs, health care costs, cognitive impairment, memory impairment, decision-making, energy levels, disease awareness
MeSH terms
Adolescent, Adult, Child, Cognition, Humans, Middle Aged, Quality of Life, Rhinitis, Allergic, Perennial, Self Concept, Workplace, Anti-Allergic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The burden of allergic rhinitis: beyond dollars and cents. https://app.cochat.ai/papers/10.1016/s1081-1206(10)62022-4
The paper
Fineman, S. M. (2002). The burden of allergic rhinitis: beyond dollars and cents. Annals of Allergy, Asthma & Immunology. https://doi.org/10.1016/s1081-1206(10)62022-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.